Poland· PL-100250828
Aminoplasmal B. Braun 10%
A aminosäuren product containing produkt złożony, registered in Poland by B. Braun Melsungen AG. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Aminosäuren is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA01 (aminosäuren), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Aminosäuren · ATC B05BA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Produkt złożony
- Manufacturer
- B. Braun Melsungen AG
- Country
- Poland (PL)
- ATC code
- B05BA01
- ATC class
- Aminosäuren
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991203634
- gtin05909991203641
- gtin05909991203658
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for aminosäuren.
Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aminosäuren · interactions on record
4 records
- 4 moderate
Most severe, free to view
- AmfetamineN06BA01moderate
- DexamfetamineN06BA02moderate
- MetamfetamineN06BA03moderate
- LisdexamfetamineN06BA12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B05BA01
Aminosäuren, as other registers publish it.
- Canada20% PROSOLBAXTER CORPORATION
- FinlandAminessPfizer Health Ab
- PolandAminomix 1 NovumFresenius Kabi Deutschland GmbH
- FinlandAminoplasmalB. Braun Melsungen AG
- DenmarkAminoplasmalB. Braun Melsungen
- PolandAminoplasmal 15%B. Braun Melsungen AG
- CzechiaAMINOPLASMAL 15%B. Braun Melsungen AG, Melsungen
- CzechiaAMINOPLASMAL 15%B. Braun Melsungen AG, Melsungen
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/48042f48-e71c-47c5-a1d8-4a605f4e62f1 GET /v1/drugs/48042f48-e71c-47c5-a1d8-4a605f4e62f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "-",
"packaging": "05909991203634 ¦ Rp ¦ 106032\n6 butelek 1000 ml\n05909991203641 ¦ Rp ¦ 106033\n10 butelek 250 ml\n05909991203658 ¦ Rp ¦ 106034\n10 butelek 500 ml",
"substance": "Leucinum 8.9 mg/ml + Lysini acetas 5.74 mg/ml + Lisinum monohydricum 3.12 mg/ml + Methioninum 4.4 mg/ml + Phenylalaninum 4.7 mg/ml + Treoninum 4.2 mg/ml + Tryptophanum 1.6 mg/ml + Valinum 6.2 mg/ml + Arginina 11.5 mg/ml + Histidinum 3 mg/ml + Alaninum 10.5 mg/ml + Glicyna 12 mg/ml + Acidum asparaginicum 5.6 mg/ml + Glutamic acid 7 mg/ml + prolina 5.5 mg/ml + Serinum 2.3 mg/ml + Tyrosine 0.4 mg/ml + izoleucyna 5 mg/ml",
"common_name": "Produkt złożony",
"pl_product_id": "100250828",
"pozwolenie_nr": "22232",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about aminosäuren.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.